Rybelsus
/
Rybelsus is an oral medication belonging to the class of GLP-1 receptor agonists, indicated for the treatment of type 2 diabetes to improve glycemic control. It is available as a once-daily oral tablet and requires a prescription. Patients are advised to be aware that Rybelsus may cause gastrointestinal side effects and should not be used in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
What is Rybelsus
Rybelsus is a prescription medication that contains the active ingredient semaglutide. It is used for the treatment of type 2 diabetes in adults to help improve blood sugar control. The drug works by mimicking the action of a hormone called GLP-1, which increases insulin secretion and decreases glucagon secretion in response to meals. This helps to lower blood sugar levels. There are other medications in the same class, known as GLP-1 receptor agonists, which include injectable forms like Ozempic and Victoza, also containing semaglutide and liraglutide, respectively. Rybelsus is unique as it is the first oral GLP-1 receptor agonist available.
25
commonly-prescribed
medication.